Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

(2016) Shin-ichi Tamura et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus

(2016) Young-Tae Lee et al.   JOURNAL OF VIROLOGY

The cytokine storm of severe influenza and development of immunomodulatory therapy

(2015) Qiang Liu et al.   Cellular & Molecular Immunology

AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection

(2014) Yu-Na Lee et al.   VACCINE

Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection

(2012) D. M. Brown et al.   JOURNAL OF VIROLOGY

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

(2012) Min-Chul Kim et al.   MOLECULAR THERAPY

Division of labor between subsets of lymph node dendritic cells determines the specificity of the CD8+ T-cell recall response to influenza infection

(2011) Jenny E. Suárez-Ramírez et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles

(2010) Jae-Min Song et al.   ANTIVIRAL RESEARCH

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

(2010) Zhiwei Sui et al.   ARCHIVES OF VIROLOGY

Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

(2010) K. El Bakkouri et al.   JOURNAL OF IMMUNOLOGY

COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research

(2010) Luis A. Brito et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines

(2010) Alain C. Tissot et al.   PLoS One

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses

(2010) Graeme E. Price et al.   PLoS One

Increasing M2 epitope density enhances systemic and mucosal immune responses to influenza A virus

(2009) Shaobo Pei et al.   BIOTECHNOLOGY LETTERS

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

(2009) Gavin J. D. Smith et al.   NATURE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

(2009) Tong-Ming Fu et al.   VACCINE

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine

(2009) Fan Wu et al.   VACCINE

An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2

(2008) Marina De Filette et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform

(2008) Jérôme Denis et al.   VACCINE

CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine

(2008) Dubravka Grdic Eliasson et al.   VACCINE

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

(2007) Juliana Bessa et al.   EUROPEAN JOURNAL OF IMMUNOLOGY